R&D and Innovation in Sustainable Chemistry

ANDA and Dossier Filing status GPI IP GIL IP Filing Status South Total USA USA Europe Canada UK Others Africa Approved 24 57 5 6 3 1 72 Tentatively Approved 1 2 - 2 - - - To be approved 5 12 3 1 6 3 25 Total Products 30 71 8 7 6 3 4 99 Analgesics CNS Other areas Cardiovascular Anti-diabetic Mineral supplements ANDA/Dossier filed - Therapeutic area wise 13 11 9 5 4 3 Anti-gout 3 Anti-Histamines Antitussives 22 29 24

View entire presentation